2018 will be another busy year for the UroGPO network. UroGPO has launched initiatives to prepare groups for new therapies on the horizon for advanced cancers (M0 CRPC, bladder and renal), and is actively deploying operational resources for existing therapies…
CVS Caremark reopens application process for dispensing physicians CVS Caremark, the nation’s second-largest Prescription Benefit Manager, had previously excluded dispensing physicians from applying to access its network. As a result of industry collaboration, co-led by UroGPO, it reopened the application process…
Provenge and men with advanced prostate cancer At the fall meeting, Paul Schellhammer, of Urology of Virginia, presented insights on the immunotherapy Provenge (sipuleucuel-T), leading the group through a perspective on the drug’s path to FDA approval for men with…
Major Dan Rooney UroGPO is proud of the partnership forged with Major Dan Rooney and his Folds of Honor foundation. Together, we have raised over $32,000 toward educational scholarships for the children and spouses of fallen and disabled service members. Air Force…
UroGPO remains committed to being 100 percent focused on urology. As the urology landscape evolves, UroGPO has continued to deliver the resources and support that drive the clinical, operational and financial success of urology practices. UroGPO has been with you…